Controlling postop pain, inflammation in cataract patients: drug delivery vs drops

Video
Conference|AAO

John A. Hovanesian, MD, discusses the highlights of his presentation on a clinical study evaluating dexamethasone vs prednisolone acetate 1% in controlling postop pain/inflammation in sequential cataract surgery patients.


John A. Hovanesian, MD, clinical instructor, UCLA Jules Stein Eye Institute, Laguna Hills, CA, discusses the highlights of his presentation titled "The D3 Study: Drug Delivery vs Drops — A Prospective Clinical Study Evaluating Dexycu vs Prednisolone Acetate 1% in Controlling Post-operative Pain and Inflammation in Patients Undergoing Sequential Cataract Surgery," during the virtual 2020 American Academy of Ophthalmology (AAO) meeting.

See more AAO coverage here

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Subscribe Now!
Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
2 experts in this video
3 experts are featured in this series.
2 experts in this video
Related Content
An image of two older adults on a bench. Concept image for giant cell arteritis and vision loss from sudden ocular change in vasculitis. Image credit: ©C Coetzee/peopleimages.com – stock.adobe.com

European Commission expands upadacitinib (Rinvoq) indication to include giant cell arteritis

Hattie Hayes
April 8th 2025
Article

Patients with GCA, an autoimmune disease, are at risk for sudden vision loss which can be permanent

PHOTON Results and Their Relation to DME Patients in Your Practice

PHOTON Results and Their Relation to DME Patients in Your Practice

July 25th 2024
Podcast

John Kitchens, MD, is joined by Diana Do, MD, to discuss the PHOTON trial results and their relation to patients with diabetic macular oedema in clinical practice.

A close-up of a doctor's face. The doctor wears PPE including a mask and safety goggles. Oncology and ophthalmology concept image. Image credit: ©H_Ko – stock.adobe.com

New study investigates ocular involvement in multiple myeloma

Lynda Charters
April 1st 2025
Article

Hematologists and ophthalmologists could work together for earlier diagnoses, research findings indicate

PULSAR Results and Their Relation to nAMD Patients in Your Practice

PULSAR Results and Their Relation to nAMD Patients in Your Practice

July 24th 2024
Podcast

John Kitchens, MD, is joined by David Brown, MD, to discuss the PULSAR study results and their relation to patients with neovascular age-related macular degeneration in clinical practice.

A child with myopia is fitted for glasses in an optometrist or ophthalmologist or optician office. Concept for paediatric myopia and refractive correction. ©chomplearn_2001 – stock.adobe.com

Paediatric myopia study indicates lens thickness and power changes closely associated with age

Lynda Charters
March 28th 2025
Article

The study assessed a large paediatric cohort for changes in spherical equivalent refraction, axial length, lens power and lens thickness

European Union flags outside the European Commission, where the Alcon Clareon Vivity IOL received a CE mark. Image credit: ©Arcady – stock.adobe.com

Alcon Clareon Vivity IOL receives CE mark, European commercialisation announced

Hattie Hayes
March 25th 2025
Article

The lens will be available with the Monarch IV manual delivery system in Q2 and the AutonoMe Automated Pre-Loaded Delivery System in Q3

© 2025 MJH Life Sciences

All rights reserved.